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Lactoferrin was purported in consumer literature to enhance and support the immune system response through
their antioxidant, antibacterial, and anticarcinogenic properties. To improve the effectiveness of lactoferrin,
liposomes were used as a carrier in this study. The main purpose of this study was to compare three different
methods to prepare the lactoferrin nanoliposomes based on the encapsulation efficiency and size distribution and
evaluate the stability and cellular uptake of lactoferrin nanoliposomes. Encapsulation efficiency and size distribution
indicated the reverse-phase evaporation method was fit for preparing the lactoferrin nanoliposomes. The stabilities
of lactoferrin nanoliposomes in simulated gastrointestinal juice, sonication treatment time and lipoperoxidation
extent of storage time were evaluated. The lactoferrin nanoliposomes showed an acceptable stability in simulated
gastrointestinal juice at 37°C for 4 h and short treatment times were required to achieve nano-scaled liposomes.
Furthermore, the viability of cells was decreased by increasing the concentration of the various lactoferrin
nanoliposomes. The methyl thiazolyl tetrazolium results demonstrated that Lf nanoliposomes and Lf activated in
the cells in a manner of dose-effect relation and Lf nanoliposomes had a statistically significantly different (p<0.01)
between the concentration 5 and 10 mg/mL. According to the results, nanoliposomes may be fit for the oral
administration of lactoferrin and could be useful approach for lactoferrin availability in tumor cells.
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Lactoferrin (Lf ) is an 80 kDa iron-binding glycoprotein
of the transferrin family, which was first isolated from
milk by Groves [1]. Lf is abundant in milk and other bio-
logical fluids, such as tears, saliva, mucous, pancreatic
juice, bile and so on. Lf is a protein with multiple bio-
logical functions, and it is not only involved in iron
transport, but also has immune response, tioxidant acti-
vities, antimicrobial activities, especially in anticarcino-
genic activities [2-6]. Bezault found that Lf made solid
tumor growth decreased and strongly inhibited experi-
mental metastasis in mice [7]. In addition, Campbell [8]
had demonstrated that Lf may be down-regulated in
some cancers, such as human breast carcinoma and
showed that it may regulate cell proliferation.* Correspondence: Rongfaguan@163.com; yihangwu@126.com
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in any medium, provided the original work is pAs a vital role in food, proteins were able to form gels
and emulsions, which allowed them to be an important
material for the encapsulation of bioactive compounds
[9,10].
One of the significant efforts towards this aim
had been the use of colloidal delivery systems such as
liposomes, micro- or nanoparticles [11]. There had been
considerable interest in liposomes [12], as they may
be used for protection in food and pharmacy system
[13-16]. Besides, nanoliposomes had the advantages of
nanoparticles, which improved the targeting and absorp-
tion into the intestinal epithelial cells [17,18]. In this
case, nanoliposomes could be used as a potential carrier
in food system.
The aim of present study was to choose the best
method to develop the Lf nanoliposomes and investigate
the stability of Lf nanoliposomes under different condi-
tions, especially in the simulated gastrointestinal tract.
The nanoliposomes were characterized by means of en-
capsulation efficiency and particle size. Furthermore, theOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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lular uptake and the effect on tumor cells.
Material and methods
Materials
Phosphatidylcholine (PC) was purchased from Beijing
Shuangxuan Microbe Culture Medium Products Factory
(Beijing, China). Cholesterol (CH), pepsin and steapsin
were obtained from Shanghai Chemical Reagent Co.
(Shanghai, China). Lactoferrin was purchased from See-
bio Company (Shanghai, China). Chloroform, diethyl ether
and Tween 80 were obtained from Hangzhou Jiachen
Chemical Company. All chemicals were of reagent grade
and used without further purification.
Methods
Lactoferrin nanoliposomes preparation
Three different methods were carried out to prepare Lf
nanoliposomes.
Reverse-phase evaporation method
Lf nanoliposomes were prepared by reverse-phase evap-
oration method [19]. Briefly, a certain amount of PC and
CH were dissolved in chloroform-diethyl ether and Lf
was dissolved in phosphate buffer solution (pH7.4). The
organic phase was mixed with the aqueous phase using
probe sonication for 5 min. The mixture was placed in a
round-bottom flask and a gel was formed by evaporating
the organic solvent under reduced pressure at 35°C
using a rotary evaporator. Then 30 mL phosphate buffer
solution (0.20 M, pH 7.4, PBS) containing tween 80 was
added and evaporated for another 20 min.
Film method
The method of preparing Lf nanoliposomes was
described by Bangham and Lea [20]. Lipids were dis-
solved in chloroform-diethyl ether forming a mixture.
The organic solvent was then removed by rotary evapo-
ration under reduced pressure at 35°C using a rotary
evaporator. The dry lipid film was hydrated with a solu-
tion of Lf dissolved in phosphate buffer solution
(0.20 M, pH 7.4, PBS).
Ether injection method
The method of preparing Lf liposomes was described by
Dream and Bangham [21]. PC and Chol were dissolved
in a certain volume of diethyl ether and the Lf was dis-
solved in amount of phosphate buffer (0.02 M, pH7.4).
The organic solution was injected into the aqueous solu-
tion. The mixture was placed into a glass bottle fitted
with a silicone rubber injection cap and this bottle was
placed in a water jacket connected to a circulating water
bath maintained at 35°C with rapid mixing until diethyl
ether removed.Characterization of lactoferrin liposomes
The particle size was measured by Mastersizer 2000 in-
strument (Malvern), equipped with HydroMu dispersing
unit (Malvern). Measurements were taken in the range
between 0.1 and 1000 μm, under the following condi-
tions: water refractive index 1.33, and general calculation
model for irregular particles. The data obtained were
averaged by software (Mastersizer 2000).
Encapsulation efficiency determination (EE)
The encapsulation efficiency was determined by centrifuge-
UV method. Take nanolipsomes suspension (500 μL) by
spinning at 10000 rpm for 30 min using centrifuge, the
protein content of the supernatant was measured by
Bradford. The same suspension was ruptured using suf-
ficient volume of ethanol, and the total amount of Lf
was determined spectrophotometrically.
Encapsulation efficiency was calculated using Eq.1.
EE% ¼ Qt  Qf
Qt
∗100 ð1Þ
Where Qf is the amount of free Lf and Qt is the total
amount of Lf present in 500 μL of nanoliposomes.
Stability of lactoferrin liposome
Malondialdehyde (MDA) Value
Lf nanoliposomes were stored in a refrigeratory at 4°C.
The MDA value was determined as an index of the PL
peroxidation. The MDA value was detected spectropho-
tometrtically by the thiobarbituric acid (TBA) reaction
following the method of Weng and Chen [22]. Taking
5 mL of a mixture of 25 mmol/L TBA, 0.9 mol/L TCA
and 50 mmol/L HC1 in a test-tube and 1 mL Lf nanoli-
posomes was heated to 100°C for 30 min and After
reaching the room temperature, the absorbance of the
solutions were measured at 535 nm.
Effect of sonication
Lf nanoliposomes (10 ml) were put into a 30 mL beaker
and were ultrasonicated with a probe sonicator
(VCX400, Sonics & Material, Inc., USA) in an ice bath
with 1 s ON, 1 s OFF intervals. Samples of 0.2 mL were
taken at predetermine intervals. Encapsulation efficiency
of withdrawn samples was determined. The release
ratios were calculated.
In vitro release of lactoferrin from nanoliposomes
The controlled release was examined in simulated gas-
tric juice of pH 1.3 and intestinal juice of pH 7.5. The
solution of pH 1.3 consisted of HCl(0.10 M), pepsin and
deionized water, while the solution of pH 7.5 was made
up of KH2PO4 (6.8 mg/mL), NaOH (0.10 M, adjusted to
pH 7.5), Trypsin (10 mg/mL) and deionized water. Five
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with the equal volume of simulated gastrointestinal juice
in a 50 mL beaker. The beaker was placed on a magnetic
stirrer adjusted to a constant speed of 150 rpm at 37°C.
Aliquots of 0.2 mL were sampled from the beaker at
predetermine intervals. The release of Lf from nanolipo-
somes was evaluated by release ratio. The release ratio
was calculated using the Eq. (2).




Where EE0 is the encapsulation efficiency of lactofer-
rin nano-liposomes before incubation and EEt is the en-
capsulation efficiency of lactoferrin nanoliposomes after
incubation for the time.Figure 1 Size distribution of Lf liposomes prepared by (A) reverse-ph
method, after 20 min of sonication at ice bath and pH 7.4.Cellular uptake studies
Cell viability was measured by the MTT assay [23].
Caco-2 cells (CBCAS, Shanghai, China) were cultured
in DMEM (Gibco, MD, US). Cells were cultured at 37°C
with 5% CO2. Cells were passaged thrice a week.
At 80% confluence, the cells were subcultured into the
96-well plates. After the monolayer of cells became
formed for 36 h, cells were treated with a range of
concentrations of different Lf nanoliposomes and Lf.
After the 24 h treatment, we renewed the serum-free
medium containing 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT, 0.5 mg.ml-1) and
allowed to grow for another 4 h. The MTT assay
assessed cell-viability by measuring the enzymatic reduc-
tion of yellow tetrazolium MTT to a purple formazan, as
measured at 570 nm using Enzyme-labeled instrument


















Figure 2 The effect of three different methods on
encapsulation efficiency of lactoferrin nanoliposomes. Data


































Figure 4 The effect of particle size and release ratio on Lf
nanoliposomes after storage at 4°C. Data reported are the mean
values ± standard variation of three replications.
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The results were expressed as the mean ± standard de-
viation (SD). The statistical study was performed using
SPSS, version 15.0 for windows.
Results and discussion
Characterization of lactoferrin liposomes
Particle size
In Figure 1 it can be observed size distribution of Lf
nanoliposomes prepared by the three different me-
thods. The size distribution is generally used as a
characterization tool to evaluate the stability of Lf
nanoliposomes. The result showed that the size of
nanoliposomes was ranked in the following order,
reverse-phase evaporation method< ether injection
method <film method.
Encapsulation efficiency
The effect of three different methods on encapsulation
efficiency of Lf nanoliposomes is shown in Figure 2. The
















Figure 3 Variation of the MDA values in Lf nanoliposomes
during storage at 4°C for 30 days. Data reported are the mean
values ± standard variation of three replications.evaporation method, ether injection method and film
method was 50.1%, 34.5% and 48.9%, respectively.
Above all, reverse-phase evaporation method is a sim-
ple and applicable operation to most of the phospholipid
mixture encapsulation volume and has high encapsula-
tion efficiency. This method is suitable for wrapping
water soluble drugs and macromolecular biologically ac-
tive substance.
Stability of lactoferrin liposome
Malondialdehyde (MDA) value
Phospholipid was used as the major component of lipo-
somal membrane, containing partially polyunsaturated
fatty acid residues sensitive to oxidative free radicles
[26]. The MDA, which as a final product of fatty acid
peroxidation was evaluated in the study. During 30 days





















 simulated gastric juice
simulated intestinal juice
Figure 5 The effect of simulated gastrointestinal juice on
nanoliposomes. Data reported are the mean values ± standard






















Figure 6 Cell viability of Caco-2 cells treated with different
concentrations of nanoliposomes and Lf. Data reported are the
mean values ± standard variation of three replications.(** P<0.01).
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shown in Figure 3. The result showed the Lf nanolipo-
somes could be stable in a period of time.
Effect of sonication
Sonication was used to form a w/o emulsion with the
REV method, and to control and reduce the size of
microvesicles [27]. The stability of Lf nanoliposomes was
evaluated by measuring the change of particle size and
release ratio after storage at 4°C for 30 days was shown
in Figure 4. After 25 min sonication on nanoliposomes,
the release ratio was 15.12% which was higher than the
release ratio of 20 min sonication. This may be caused
by the extension of ultrasonic total time, the crushed
particles had been gained new energy, resulting in a
change of stability . With time increased, the size of
nanoliposomes became smaller. This is due to ultra-
sound phenomena in liquid media enhance mass trans-
ports of their constituents in a non-homogeneous
fashion allowing the fast formation of vesicles [28]. After
20 min sonication on Lf nanoliposomes, the particle size
did not change so much. Above all, the 20 min sonic-
ation time on Lf nanoliposomes may be fit for preparing.
In vitro release of lactoferrin from nanoliposomes
When Lf nanoliposomes could be used as carriers for
the oral administration of Lf, they must be able to with-
stand passage through the stomach and small intestine.
In vitro release has been used as a very important surro-
gate indicator of in vivo performance.
Figure 5 showed the release ratio of Lf from nanolipo-
somes in simulated gastrointestinal juice. About 23% Lf
was released from nanoliposomes within 4 h in the
simulated gastric juice. However, because food usuallyremains in the stomach for more or less 4 h, the liposo-
mal Lf could be effectively protected in the gastric juice
[29]. In simulated intestinal juice, bile salts and pancre-
atic lipase may cause the Lf release from nanoliposomes
[30]. This phenomenon may increase the release of
nanoliposome.
Cell viability
After cells were incubated with 1, 2.5, 5, 10 mg·mL-1 of
Lf nanoliposomes for 24 h, compared with the Lf in con-
trol experiments. Figure 6 showed the MTT results
demonstrated a concentration dependent uptake after
exposure to Lf nanoliposomes. With the same concen-
tration, the cell activity of Lf nanoliposomes is lower
than the cell activity of Lf. It is observed that the cell ac-
tivity is a statistically significantly different (p<0.01) be-
tween the concentration 5 and 10 mg/mL. The MTT
results showed that Lf nanoliposomes and Lf activated
in the cells in a manner of dose-effect relation and Lf
nanoliposomes has a more obvious function to the cells
(p<0.01). The possibility of both targeting drugs to spe-
cific tissues and cells, and facilitating their uptake and
cytoplasmic delivery has rendered liposomes a versatile
drug carrier system with numerous potential applica-
tions in medicine [31].
Conclusions
Lf nanoliposomes with high encapsulation efficiency
were prepared successfully by REV method. The particle
size indicated the stability of the Lf nanoliposomes sus-
pension. Lf nanoliposomes were tested in vitro for their
stability in simulated gastrointestinal juice. The Lf nano-
liposomes showed an acceptable stability in simulated
gastrointestinal juice at 37°C for 4 h. According to the
results, Lf nanoliposomes may be fit for use in the oral
administration. The uptake of Lf nanoliposomes formu-
lations were found to depend on concentration. In con-
clusion, we have demonstrated that Lf nanoliposomes
with different concentration could modulate the growth
of tumor cells.
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